Atovaquone ≥98%, Moligand™

Supplier: ALADDIN SCIENTIFIC CORPORATION
Warning

Synonyms: trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione, 2-(trans-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione

A151027-1G A151027-250MG A151027-5G
ALA151027-1GEA 391.31 USD
ALA151027-1G ALA151027250MG ALA151027-5G
Atovaquone ≥98%, Moligand™
Atovaquone

Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Atovaquone belongs to the class of naphthoquinones with a broad-spectrum activity against parasitic infections including malaria, toxoplasmosis and Pneumocystis pneumonia. It is a potent antiprotozoal compound which aids in collapsing the mitochondrial membrane potential in a malaria parasite.

Formula: C₂₂H₁₉ClO₃
MW: 366.84 g/mol
Melting Pt: 223 °C
Storage Temperature: Freezer
MDL Number: MFCD00889188
CAS Number: 95233-18-4
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=f8a8f7358d050fe392fba6f05d69771b9c783cf0&vid=f8a8f7358d050fe392fba6f05d69771b9c783cf0&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR